Detalhe da pesquisa
1.
Previous radiotherapy improves treatment responses and causes a trend toward longer time to progression among patients with immune checkpoint inhibitor-related adverse events.
Cancer Immunol Immunother
; 72(10): 3337-3347, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37486396
2.
Treatment outcomes of non-small cell lung cancers treated with EGFR tyrosine kinase inhibitors: a real-world cohort study.
Acta Oncol
; 62(12): 1854-1861, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37934101
3.
Purchase of prophylactic topical corticosteroids is associated with improved survival in NSCLCs treated with EGFR TKI: real-world cohort study.
Acta Oncol
; 60(9): 1100-1105, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34137354
4.
Electronic patient-reported outcomes and machine learning in predicting immune-related adverse events of immune checkpoint inhibitor therapies.
BMC Med Inform Decis Mak
; 21(1): 205, 2021 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34193140
5.
Digital Monitoring and Management of Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Treated With Cancer Immunotherapy and Its Impact on Quality of Clinical Care: Interview and Survey Study Among Health Care Professionals and Patients.
J Med Internet Res
; 22(12): e18655, 2020 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33346738
6.
Possibilities of Improving the Clinical Value of Immune Checkpoint Inhibitor Therapies in Cancer Care by Optimizing Patient Selection.
Int J Mol Sci
; 21(2)2020 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31952311
7.
Early PD-1 Therapy Discontinuation in Responding Metastatic Cancer Patients.
Oncology
; 96(3): 125-131, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30380551
8.
A national precision cancer medicine implementation initiative for Finland.
Acta Oncol
; 63: 395-397, 2024 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38779937
9.
Assessment of chemotherapy-induced neurotoxicity using a point-of-care nerve conduction study device.
Cancer Rep (Hoboken)
; 6(1): e1677, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35818348
10.
ePRO symptom follow-up of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy is feasible and enhances the quality of patient care: a prospective multicenter study.
J Cancer Res Clin Oncol
; 149(10): 6875-6882, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36809503
11.
The prognostic and predictive roles of plasma C-reactive protein and PD-L1 in non-small cell lung cancer.
Cancer Med
; 12(15): 16087-16097, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37329173
12.
Assessing the impact of digital patient monitoring on health outcomes and healthcare resource usage in addition to the feasibility of its combination with at-home treatment, in participants receiving systemic anticancer treatment in clinical practice: protocol for an interventional, open-label, multicountry platform study (ORIGAMA).
BMJ Open
; 13(4): e063242, 2023 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37076159
13.
Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial.
Cell Rep Med
; 4(12): 101307, 2023 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38056464
14.
Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer.
J Immunother Cancer
; 11(10)2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37852738
15.
Association of Rare Immune-Related Adverse Events to Survival in Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors: A Real-World Single-Center Cohort Study.
Cancers (Basel)
; 14(9)2022 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35565405
16.
Treatment discontinuation and re-initiation of anti-PD-(L)1 agents in metastatic cancers.
J Cancer Res Clin Oncol
; 146(8): 2153-2160, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32306129
17.
Tetracyclines increase the survival of NSCLC patients treated with EGFR TKIs: a retrospective nationwide registry study.
ESMO Open
; 5(5): e000864, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33087401
18.
Follow-Up of Cancer Patients Receiving Anti-PD-(L)1 Therapy Using an Electronic Patient-Reported Outcomes Tool (KISS): Prospective Feasibility Cohort Study.
JMIR Form Res
; 4(10): e17898, 2020 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33112242
19.
Elevated CRP levels indicate poor progression-free and overall survival on cancer patients treated with PD-1 inhibitors.
ESMO Open
; 4(4): e000531, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31555483
20.
ePROs in the follow-up of cancer patients treated with immune checkpoint inhibitors: a retrospective study.
J Cancer Res Clin Oncol
; 145(3): 765-774, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30666409